iosr-JPBS   Volume-17 ~ Issue-4 ~ Jul. - Aug. 2022

[1]. World Health Organization. WHO coronavirus (COVID-19) dashboard. https://covid19.who.int.Updated2021. Accessed December 20, 2021.
[2]. World Health Organization. Coronavirus. Available from: https://www.who.int/health-topics/coronavirus#tab=tab_1.v(Accessed December 20, 2022).
[3]. Centers of Disease Control and Prevention. DifferentvCOVID-19 Vaccines. Availablefrom:https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.Html. (Accessed on December 10, 2021)
[4]. Voysey M, Costa-Clemens SA, Madhi SA et al. Israel paper safety and efficacy of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, andthe UK. Lancet 2021;9:99–111 397.
[5]. Attia S and Howaldt HP. Impact of COVID-19 on the Dental Community: Part I before Vaccine (BV). JClinMed2021;10:288.

[1]. Fedorenko ZP, Mykhalovych YuJ, Gulak LO et al. Cancer in Ukraine, 2013-2014. Bull. of the National Cancer Register 2015; (16): 1-6 (In Ukrainian).
[2]. Hu J, Ludgate L (2007). HIV-HBV and HIV-HCV coinfection and liver cancer development. Cancer Treat. Res. 133: 241–52.
[3]. Bellon M, Nicot C (2007). «Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia». Cancer genomics & proteomics 4 (1): 21–5.
[4]. Potebnya GP, Khutornoi SV, Didenko GV. (2002) Evaluation of effectiveness of antitumor vaccines obtained with the use of metabolic products of Bacillus subtilis AB-56. Exp Oncol; 24(3): 225-8.
[5]. Lisovenko GS, Potebnya GP, Kolesnik EA, Kikot VV. (2002) Application of tumor marker antigens on immunotherapy of patients with colorectal cancer. Exp Oncol; 24(4): 258-64..

[1]. A Blazovics A and Simandi B, Phenolic and triterpenoid antioxidants from Origanummajorana L., herb and extracts obtained with different solvents, J Agric Food Chem, 2005; 53: 17-21.
[2]. Singla P and Vasudeva N, Pharmacognostical and quality control parameters of Origanummajorana Linn, Stem and root, World J Pharm PharmaceutSci, 2014; 3(6): 1428-1437.
[3]. Vagi E, Simandi S, Daood H, Deak A, Sawinsky J. Recovery of pigment from Origanummajorana L. by extraction with supercritical carbon dioxide. J Agri Food Chem; 2002;50:2297-2301.
[4]. Origanummajorana and Origanumvulgarespp, Hirtum growing in India, Chem Nat Comp, 2012; 47: 6
[5]. Singla P and Vasudeva N, Pharmacognostical and quality control parameters of Origanummajorana Linn, Stem and root, World J Pharm PharmaceutSci, 2014; 3(6): 1428-1437.

[1]. Ksouri R, Megdiche Ksouri W, Jallali I, Debez A, Magné C, Hiroko I, Abdelly C. Medicinal halophytes: potent source of health promoting biomolecules with medical, nutraceutical and food applications. Critical Reviews in Biotechnology. 2012; 4:289-326.
[2]. Ignat I, Volf I, Popa V I. A critical review of methods for characterisation of polyphenolic compounds in fruits and vegetables. Food Chemistry. 2011; 126: 1821-1835.
[3]. Jallali I. Étude de la composition en antioxydants et des activités biologiques de deux halophytes: Crithmum maritimum L. et Inula crithmoïdes L. PhD thesis. Tunisia. 2016 ; pp: 132.
[4]. Rivière C, Papastamoulis Y, Fortin P Y, Delchier N, Andriamanarivo S, Waffo-Teguo P, Kapche G D W F, Amira-Guebalia H, Delaunay J C, Mérillon J M, Richard T, Monti J P. New stilbene dimers against amyloid fibril formation. Bioorganic & Medicinal Chemistry Letters. 2010; 20: 3441-3443.
[5]. Richard T, Poupard P, Nassra M, Papastamoulis Y, Iglesias M L, Krisa S, Waffo-Teguo P, Merillon J M, Monti J P. Protective effect of ε-viniferin on β-amyloid peptide aggregation investigated by electrospray ionization mass spectrometry. Bioorganic & Medicinal Chemistry. 2011; 19: 3152-3155

[1]. World Health Organization. Executive Summary Global Report on Diabetes. 2016. France: World Health Organization.
[2]. IDF Diabetes Atlas Sixth Edition. Vol 76.; 2013.
[3]. Kharroubi AT. Diabetes mellitus: The epidemic of the century. World J Diabetes. 2015;6(6):850. doi:10.4239/wjd.v6.i6.850
[4]. American Diabetes Association. Standard of medical care in diabetes- 2019. J Clin Appl Res Educ. 2019;42:204. doi:https://doi.org/10.2337/dc19-S002
[5]. Newman. General Practice Management of Type 2 Diabetes: 2016-18.; 2014. https://www.racgp.org.au/download/Documents/Guidelines/Diabetes/2015diabetesmanagement.pdf

[1]. K. Uekama, F. Hirayama, and T. Irie, "Cyclodextrin Drug Carrier Systems," Chem. Rev., vol. 98, no. 5, pp. 2045–2076, Jul. 1998, doi: 10.1021/cr970025p.
[2]. S. Amiri and S. Amiri, Cyclodextrins: properties and industrial applications. John Wiley & Sons, 2017.
[3]. J. S. Hadi and M. H, "p-amino benzoic acid Schiff base and their cyclodextrins inclusion complexes,"J.of pharmacy, vol. 11, no. 11,
[4]. L. Liu and Q.-X. Guo, "The Driving Forces in the Inclusion Complexation of Cyclodextrins," J. Incl. Phenom. Macrocycl. Chem., vol. 42, no. 1, pp. 1–14, 2002, doi: 10.1023/A:1014520830813.
[5]. P. Jansook, N. Ogawa, and T. Loftsson, "Cyclodextrins: structure, physicochemical properties and pharmaceutical applications," Int. J. Pharm., vol. 535, no. 1–2, pp. 272–284, 2018, doi: 10.1016/j.ijpharm.2017.11.018.

[1]. Sriroth K, Wanlapatit S, Piyachomkw K. Cassava Bioethanol. In: Bioethanol. InTech; 2012
[2]. Hikmiyati N., D. Noviea, S. Yanie. Pembuatan bioetanol dari limbah kulit singkong melalui proses hidrolisa asam dan enzimatis. 2009.
[3]. Sarkar N., S.K. Ghosh, S. Bannerjee, K. Aikat. Bioethanol production from agricultural wastes: An overview. Vol. 37, Renewable Energy. 2011. p. 19–27.
[4]. Pusdatin. Buku Pegangan Statistik Ekonomi Energi Indonesia DESDM. Jakarta: Pusat Data dan Informasi Energi dan Sumber Daya Mineral KESDM; 2010. 198 p.
[5]. Bantacut T., F. Ramadhani. Development of a closed production process of tapioca industry. International Journal of Advanced Research. 2018 Sep 30;6(10):521–32

[1]. Braun, J., Zochling, J., Baraliakos, X., Alten, R., Burmester, G., Grasedyck, K., ... &Sieper, J. (2006). Efficacy of sulfasalazine in patients with inflammatory back paindue to undifferentiated spondylo arthritis and early ankylosing spondylitis: amulticenter randomized controlled trial. Annals of the rheumatic diseases, 65(9),1147-1153.
[2]. https://sci-hub.ee/10.1136/ard.2006.052878
[3]. Zhen, H., Kang, C., & Liu, Y. (1993). Clinical Observation on 85 Patients withAnkylosing Spondylitis at Active Stage Treated by Shudu Bushen Recipe Togetherwith Western Medicine. Journal of Traditional Chinese Medicine, (03).http://wprim.whocc.org.cn/admin/article/articleDetail?WPRIMID=533708&articleId=533708
[4]. https://sci-hub.se/http://wprim.whocc.org.cn/admin/article/articleDetail?WPRIMID=533708&articleId=533708
[5]. Cantarini, L., Tinazzi, I., Biasi, D., Fioravanti, A., & Galeazzi, M. (2007). Sulfasalazine-induced immune thrombocytopenia. Postgraduate medical journal, 83(980), e1-e1.https://pmj.bmj.com/content/83/980/e1.short

[1]. Lina Abdel Salam, Mona Abdelmottaleb and Ahmed Geneidi : Archives of Pharmaceutical Sciences Ain Shams University, 'Formulation and Characterization of Proniosomal Gels Loaded with Levofloxacin for Dermal Drug Delivery', 5 (2021), 288-303.
[2]. Aya AbuElfadl, Mariza Boughdady and Mahasen Meshali : International Journal of Nanomedicine, 'New Peceol™/Span™ 60 Niosomes Coated with Chitosan for Candesartan Cilexetil: Perspective Increase in Absolute Bioavailability in Rats', 16 (2021), 5581.
[3]. S Agarwal, Vasudha Bakshi, P Vitta, AP Raghuram and N Udupa : Indian Journal of pharmaceutical sciences, 'Effect of Cholesterol Content and Surfactant Hlb on Vesicle Properties of Niosomes', 66 (2004), 121.
[4]. Mohammed S Alqahtani, Mohsin Kazi, Mohammad A Alsenaidy and Muhammad Z Ahmad :Frontiers in Pharmacology Ahmad, 'Advances in Oral Drug Delivery', (2021), 62.
[5]. Reham Mokhtar Aman, Irhan Ibrahim Abu Hashim and Mahasen Mohamed Meshali :European Journal of Pharmaceutical Sciences, 'Novel Chitosan-Based Solid-Lipid Nanoparticles to Enhance the Bio-Residence of the Miraculous Phytochemical "Apocynin"', 124 (2018), 304-18

[1]. Ezzoubair, K., 2018. L'intérêt de la sécurisation biologique en transfusion sanguine pour lutter contre les agents pathogènes. (PhD Thesis).
[2]. Coly, M.N., Sarr, H., Makalou, D., 2020. Hémotypologie et séroprévalence des marqueurs infectieux chez les donneurs de sang à l'Hôpital de la paix de Ziguinchor, Sénégal.
[3]. Goita, A.A., 2018. Place de la transfusion sanguine dans la prise en charge des urgences obstétricales dans le service de gynécologie obstétrique du Centre de Santé de Référence de la Commune V du District de Bamako.
[4]. Pessoni, L.L., Aquino, É.C. de, Alcântara, K.C., 2019. Prevalence and trends in transfusion-transmissible infections among blood donors in Brazil from 2010 to 2016. Hematology, transfusion and cell therapy 41, 310–315.
[5]. Cissé, M., 2020. La Séroprévalence des marqueurs biologiques chez les donneurs de sang de Janvier à Décembre 2018 au Centre Hospitalier Universitaire de Gabriel Toure (PhD Thesis). Université des Sciences, des Techniques et des Technologies de Bamako.